Thu, 13 Nov 2008 19:46:35 +0000
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters)- Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S. researchers reported on Thursday. The.
Thu, 13 Nov 2008 19:07:56 +0000
Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S. researchers reported on Thursday.
Thu, 07 Aug 2008 03:38:46 +0000
Cisplatin, cisplatinum or cis-diamminedichloridoplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class.
Fri, 18 Jul 2008 14:50:58 +0000
Chemotherapy is one of the important means to treat lung cancer. Unfortunately chemotherapy will also injure normal cells while killing cancer cells. Gastrointestinal reaction is the most common chemotherapy drug reactions, including nausea, vomit, diarrhoea, abdominal distension, etc, most patients feel unwell.
Mon, 19 May 2008 16:00:46 +0000
Eli Lilly & Co. said giving advanced lung cancer patients its Alimta drug after chemotherapy increased patients' survival without tumor recurrence or progression.
Wed, 20 Feb 2008 10:41:06 +0000
After surgery and chemotherapy, when the cancer reappeared and spread, the patient sought online advice, receiving recommendations of new drugs and drug combinations, and a focus on maintaining quality of life.
Wed, 30 Jan 2008 19:03:53 +0000
Treatment and Prognosis Inherent and acquired drug resistance is a cause of chemotherapy failure, and pharmacogenomic studies have begun to define gene variations responsible for varied drug metabolism, which influences drug efficacy.
Fri, 19 Oct 2007 04:11:17 +0000
WASHINGTON- Genentech Inc colon and lung cancer drug Avastin, along with standard chemotherapy, increases survival rates of patients with a very deadly type of brain tumor, U.S. researchers said on Thursday.
Wed, 03 Oct 2007 08:52:28 +0000
The United States Food and Drug Administration (FDA) recently approved the chemotherapy agent TaxotereŽ (docetaxel), in combination with PlatinolŽ (cisplatin) and 5-fluorouracil, for use prior to surgery and chemoradiation therapy for the treatment of locally advanced squamous cell head and neck cancer. Taxotere is also approved for breast, lung, g
Sat, 01 Sep 2007 11:45:46 +0000
A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).Known as the retinoblastoma (RB) tumor suppressor, this fundamental molecule regulates cell proliferation in the body.
Thu, 28 Jun 2007 03:09:29 +0000
Once cancer has spread to other parts of the body, chemotherapy and radiotherapy replace surgery as the main treatment options. A number of drugs are available, and many more are being tested in clinical trials. Radiotherapy is palliative, and while it may ease symptoms such as pain and cough, it will not stop cancer growth.
Wed, 27 Sep 2006 15:35:19 +0000
An experimental lung cancer drug has extended patients' life expectancy by more than 50% in preliminary trials. Patients given the drug AS1404 on top of standard chemotherapy lived an average of 14 months compared with 8.8 months if given chemotherapy alone. The drug belongs to a new class of compounds called vascular disrupting agents.
Sat, 23 Sep 2006 06:00:35 +0000
Duke University Medical Center scientists have developed the first-ever genomic test to predict which patients with early-stage lung cancer will need chemotherapy to live and which patients can avoid the toxic regimen of drugs.